CytRx Corporation announced that it has increased the number of directors of the company from five to six and appointed Eric J. Selter as a member of Board of Directors. The board also appointed Mr. Selter as the Chairman of the Audit Committee and as a member of the Compensation Committee of Board. Such positions include Chief Operating Officer since 2000, Senior Vice President since 2006, and Secretary from 2006 to 2011, then again from 2013 to present.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.76 USD | -4.83% | -4.83% | +112.31% |
15/05 | LadRx Corporation Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
27/03 | LadRx Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+112.31% | 1.37M | |
+43.36% | 54.64B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+0.04% | 12.16B | |
+25.12% | 12.21B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- LADX Stock
- News LadRx Corporation
- CytRx Corporation Announces Board Changes